Netpharm Consulting ApS: Financial statements 2020
CVR: 41104554
Source: annual report 2020, Danish Business Authority
22/01/2020 – 31/12/2020
Netpharm Consulting ApS (CVR 41104554) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -12,342 and a net result of DKK -12,342. Equity in the 2020 report amounted to DKK 27,658. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -12,342
- Profit/Loss
- DKK -12,342
- Equity
- DKK 27,658
- Total Assets
- DKK 27,658
Official annual report
How creditworthy is Netpharm Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of January 22, 2020, Jakob Byong Sandersen is registered as director of Netpharm Consulting ApS.
As of January 22, 2020, Netpharm Holding ApS is registered as an owner of Netpharm Consulting ApS with an ownership share of 100%.
Netpharm Consulting ApS was founded on January 22, 2020.
About Netpharm Consulting ApS
Netpharm Consulting ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Byong Sandersen. The company is owned by Netpharm Holding ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,341 and a net result of DKK -18,341 compared with DKK -14,288 the year before. Equity in the 2025 report amounted to DKK 15,365.